Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumorsSamuel Cheshier, Gregor Hütter, Cyndhavi Narayanan et al.|Science Translational Medicine|2017Cited by 427
BET Bromodomain Inhibition of <i>MYC</i> -Amplified MedulloblastomaPratiti Bandopadhayay, Yoon‐Jae Cho, Guillaume Bergthold et al.|Clinical Cancer Research|2013Cited by 354
Supplementary Table 5 from BET Bromodomain Inhibition of <i>MYC</i>-Amplified MedulloblastomaPratiti Bandopadhayay, Yoon‐Jae Cho, Guillaume Bergthold et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from BET Bromodomain Inhibition of <i>MYC</i>-Amplified MedulloblastomaPratiti Bandopadhayay, Yoon‐Jae Cho, Guillaume Bergthold et al.|Unknown|2023Cited by 0
Supplementary Table 5 from BET Bromodomain Inhibition of <i>MYC</i>-Amplified MedulloblastomaPratiti Bandopadhayay, Yoon‐Jae Cho, Guillaume Bergthold et al.|Unknown|2023Cited by 0